← Back to Search

COVID-19 Testing Methods for Coronavirus

N/A
Waitlist Available
Led By Jason E Farley, PhD, MPH, NP
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured from testing completion to receipt of results (within 10 days of testing)
Awards & highlights

Study Summary

This trial will test different ways of testing for COVID-19 in 1,386 households in Baltimore City to find the best method.

Who is the study for?
The C-FORWARD trial is for households in Baltimore City with at least one English or Spanish-speaking adult who can consent. Households must have members willing to complete surveys and, if there are children aged 12 or older, they must also assent.Check my eligibility
What is being tested?
This study is testing three COVID-19 testing methods: standard fixed-site testing, mobile van testing within the community, and self-collected home-based tests. The goal is to find out which method works best by randomly assigning 1,386 households to one of these options.See study design
What are the potential side effects?
Since this trial involves non-invasive COVID-19 testing methods rather than medication or vaccines, side effects are minimal but may include discomfort from swab collection or anxiety related to test results.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured from testing completion to receipt of results (within 10 days of testing)
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured from testing completion to receipt of results (within 10 days of testing) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Uptake of SARS-CoV-2 testing as assessed by proportion of participants who complete testing
Secondary outcome measures
Receipt of SARS-CoV-2 testing results
Time from SARS CoV-2 testing to receipt of results
Time to completion of SARS CoV-2 testing
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Self-collected testingExperimental Treatment1 Intervention
Self-collected, home-based testing
Group II: Fixed site SOC testingExperimental Treatment1 Intervention
Fixed site Standard of Care (SOC) testing
Group III: Community-based testingExperimental Treatment1 Intervention
Community-based, mobile van testing

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,275 Previous Clinical Trials
14,837,624 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,278 Previous Clinical Trials
5,484,716 Total Patients Enrolled
Jason E Farley, PhD, MPH, NPPrincipal InvestigatorJohns Hopkins University School of Nursing
2 Previous Clinical Trials
3,677 Total Patients Enrolled

Media Library

Community-based, mobile van testing Clinical Trial Eligibility Overview. Trial Name: NCT04673292 — N/A
Coronavirus Research Study Groups: Fixed site SOC testing, Community-based testing, Self-collected testing
Coronavirus Clinical Trial 2023: Community-based, mobile van testing Highlights & Side Effects. Trial Name: NCT04673292 — N/A
Community-based, mobile van testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04673292 — N/A
~706 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top